http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012005339-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_145d98fba6456922ea2b401d650a8c46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a2b67b47c63cfa3698a038cf878aaaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63a585e44fdadfc4112f6bca00f4a034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a7993de7ca3cfc4fea38995b40ece2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e85c1115d3f78ebb33b70d98e159c0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_522dc1e17e2107269cb87a35cef3b6de
publicationDate 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012005339-A1
titleOfInvention Prophylactic or therapeutic agent for diabetes
abstract A prophylactic or therapeutic agent for diabetes, which comprises a polynucleotide such as miR-199b*; a method for screening for a prophylactic or therapeutic agent for diabetes, which comprises measuring the expression amount of a polynucleotide such as miR-199b*; and a method for determining the sensitivity to a prophylactic or therapeutic agent for diabetes, which comprises measuring the expression amount of a polynucleotide such as miR-199b*.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015510754-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020048426-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017047800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7325075-B2
priorityDate 2010-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010005295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005013901-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415253

Total number of triples: 41.